
|Videos|February 15, 2023
Case 1: Faricimab in a high-need neovascular nAMD patient
Advertisement
Dr. Khanani shares the case of a neovascular nAMD patient with high disease activity who achieved significant vision improvement and fluid resolution after switching to faricimab.
Sponsored by Roche
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy
2
8 things to know about aflibercept 8 mg for retinal vascular disease
3
The Retina TL;DR with Dr. Weng: Targeting the Fas signaling pathway with David Zacks, MD, PhD
4
First patient treated in dose-expansion portion of SpliceBio's phase 1/2 ASTRA clinical trial
5













































